This article is more than 5 years old. Information may no longer be current.

Akorn receives FDA clearance for over-the-counter topical ocular allergy drug

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

BUFFALO GROVE, Ill. — Akorn has received U.S. Food and Drug Administration approval to market ketotifen fumarate ophthalmic solution 0.025% for over-the-counter use, Akorn announced in a press release.

The drug is a generic equivalent of Novartis' Zaditor ophthalmic solution 0.025%, which was recently granted over-the-counter status. It is indicated for up to 12 hours of temporary relief for itchy eyes due to pollen, ragweed, grass, animal hair and dander.

Akorn expects to launch the product in October, according to the release.